Great Basin Scientific (GBSN) Reports Q3 EPS of $0.26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall St set for lower open as Alphabet results reignite AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Rivian shares slip ahead of Thursday earnings release
- Marvell in advanced talks to acquire Lumentum, Bloomberg reports
- Moderna stock rises on latest cancer vaccine data publication
Great Basin Reports Third Quarter 2015 Results
November 16, 2015 4:02 PM ESTSALT LAKE CITY--(BUSINESS WIRE)-- Great Basin Scientific, Inc. (NASDAQ: GBSN), a molecular diagnostic testing company, today reported financial results for the third quarter ended September 30, 2015.
Third Quarter 2015 Financial and Business Highlights
Revenue for the third quarter was $545,934, representing a 33.4% year-over-year increase 143 revenue-generating U.S. customers as of September 30, 2015 Continued adoption of its Group B Strep (GBS) assay, with over 87 customers using or evaluating the test, representing 57% of its installed base On September 1, 2015... More


